Reflexonic gets OK for ED device; Biotronik starts peripheral stent trial;

> Chambersburg, PA-based Reflexonic has received 510(k) clearance for Viberect, its erectile dysfunction device. Reflexonic release

> Biotronik has completed its first endovascular procedure for its BIOFLEX-1 clinical trial. The trial is studying the safety and performance of the company's Astron and Astron Pulsar self-expanding peripheral stents. In all, 350 patients will be enrolled in the study. Biotronik release

> Researchers at the University of Illinois are finding new ways to use glucose meters that are traditionally used by diabetics. Using DNA sensors, the meters could be used for diagnostics or environmental monitoring. Article

> The Indian state of Maharashta is considering banning ultrasounds to combat sex-selective abortions, which are illegal. Report

And Finally... PhysOrg delves into the world of facial reconstructive surgery, discussing the usage topographical optimization and prosthetics to help patients with severe craniofacial injuries. Item

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.